Klinger, J. R., Al-Hiti, H., Chang, S., Chang, H. J., Ghofrani, H., Grünig, E., . . . Meyer, G. (2025). Predicting response to switching from phosphodiesterase type 5 inhibitor to riociguat in patients with pulmonary arterial hypertension: Biomarker and responder analysis of the RESPITE and REPLACE studies. Pulmonary circulation, 15(3), . https://doi.org/10.1002/pul2.70140
Chicago-Zitierstil (17. Ausg.)Klinger, James R., et al. "Predicting Response to Switching from Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients with Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies." Pulmonary Circulation 15, no. 3 (2025). https://doi.org/10.1002/pul2.70140.
MLA-Zitierstil (9. Ausg.)Klinger, James R., et al. "Predicting Response to Switching from Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients with Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies." Pulmonary Circulation, vol. 15, no. 3, 2025, https://doi.org/10.1002/pul2.70140.